Zdrowie i gospodarka · 18/10/2006

FDA Guidance for Industry on Fixed Dose Combinations, Co-Packaged Drug Products, and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment of HIV

The FDA has released a guidance for the pharmaceutical industry to encourage the development and submission of fixed dose combination (FDC) and single-entity versions of antiretroviral drugs for HIV treatment, aiming to increase access to effective anti-HIV medications worldwide.